The company is heavily reliant on a cancer drug that could be targeted by a program intended to lower drug prices.
Merck Sues Over Medicare Drug-Price Negotiation Law
Written by
in
The company is heavily reliant on a cancer drug that could be targeted by a program intended to lower drug prices.
Written by
in